HappiCare

HappiCare is a developer of fertility testing kits and the first medical technology company in China to introduce the use of fingertip blood to test Anti-Müllerian Hormone (AMH) and assess ovarian premature failure genes for evaluating female fertility. Entering the broader women's health technology market through "fertility testing," HappiCare has pioneered the development of an at-home female fertility testing kit in China, which includes tests for AMH, sex hormones, and ovarian premature failure genes. Users only need a smartphone and a HappiCare testing kit to complete fertility testing from home. Main business areas include: technical services, technical consulting, technical transfer, and technical development in the field of biotechnology; nutritional health consultation services; information technology consulting services; exhibition services; e-commerce (not engaged in value-added telecommunications or financial services); food sales; and the sale of medical devices.